2003
Walles T, Lichtenberg A, Puschmann C, Leyh R, Wilhelmi M, Kallenbach K, Haverich A, Mertsching H. In vivo model for cross-species porcine endogenous retrovirus transmission using tissue engineered pulmonary arteries. Eur J Cardiothoracic Surg 2003 Sep; 24(3): 358-63.
Teebken OE, Puschmann C, Aper T, Haverich A, Mertsching H. Tissue-engineered bioprosthetic venous valve: a long-term study in sheep. Eur J Vasc Endovasc Surg 2003 Apr; 25(4):305-12.
Gabouev AI, Schultheiss D, Mertsching H, Köppe M, Schlote N, Wefer J, Jonas U, Stief CG. In vitro construction of urinary bladder wall using porcine primary cells reseeded on acellularized bladder matrix and small intestinal submucosa. Int J Artif Organs. 2003 Nov; 26(10): 935-42.
Walles T, Herden T, Haverich A, Mertsching H. Influence of scaffold thickness and scaffold composition on bioartificial graft survival. Biomaterials 2003 Mar; 24:1233-9.
Cebotari S, Walles T, Sorrentino S, Haverich A, Mertsching H. Guided tissue regeneration of vascular grafts in the peritoneal cavity. Circ Res 2002 May; 90:e71.
Leyh R, Wilhelmi M, Haverich A, Mertsching H. A xenogeneic acellularized matrix for heart valve tissue engineering: in vivo study in a sheep model. Z Kardiol. 2003 Nov; 92(11): 938-46.
Leyh RG, Wilhelmi M, Walles T, Kallenbach K, Rebe P, Oberbeck A, Herden T, Haverich A, Mertsching H. Acellularized porcine heart valve scaffolds for heart valve tissue engineering and the risk of cross-species transmission of porcine endogenous retrovirus. J Thorac Cardiovasc Surg 2003 Oct; 126(4): 1000-4.
Kofidis T, Akhyari P, Wachsmann B, Mueller-Stahl K, Boublik J, Ruhparwar A, Mertsching H, Balsam L, Robbins R, Haverich A. Clinically established haemostatic scaffold (tissue fleece) as biomatrix in tissue- and organ-engineering research. Tissue Eng 2003 Jun; 9(3): 517-23.
Leyh RG, Wilhelmi M, Rebe P, Fischer S, Kofidis T, Haverich A, Mertsching H. In vivo repopulation of xenogeneic and allogeneic acellular valve matrix conduits in the pulmonary circulation. Ann Thorac Surg 2003 May; 75(5):1457-63.
Walles T, Puschmann C, Haverich A, Mertsching H. Acellular scaffold implantation – no alternative to tissue engineering. Int J Art Org 2003 Mar; 26(3):225-34.
Wilhelmi MH, Gratz KF, Mischke R, von Depka M, Noske D, Francis T, Haverich A, Mertsching H. The ex-vivo-shunt-model: novel approach for assessing the thrombogenicity of vascular implants. Int J Artif Organs. 2003 Dec; 26(12): 1095-103.
Schultheiss D, Badalyan R, Pilatz A, Gabouev AI, Schlote N, Wefer J, von Wasielewski R, Mertsching H, Sohn M, Stief CG, Jonas U. Androgen and estrogen receptors in the human corpus cavernosum penis: immunohistochemical and cell culture results. World J Urol 2003 Nov; 21(5): 320-4.
Wilhelmi MH, Mertsching H, Wilhelmi M, Leyh R, Haverich A. Role of inflammation in allogeneic and xenogeneic heart valve degeneration: immunohistochemical evaluation of inflammatory endothelial cell activation. J Heart Valve Dis. 2003 Jul; 12(4): 520-6.
Mueller-Stahl K, Kofidis T, Akhyari P, Wachsmann B, Lenz A, Boublik J, Heine M, Muehlfait V, Haverich A, Mertsching H. Carboxyfluorescein diacetate succinimidyl ester facilitates cell tracing and colocalization studies in bioartificial organ engineering. Int J Art Org 2003 Mar; 26(3):235-40.
Wilhelmi MH, Rebe P, Leyh R, Wilhelmi M, Haverich A, Mertsching H. Role of inflammation and ischemia after implantation of xenogeneic pulmonary valve conduits: histological evaluation after 6 to 12 months in sheep. Int J Artif Organs. 2003 May;26(5):411-20.
Buchbeiträge
Mertsching H, Puschmann C. Impact of proteases in tissue engineering and regeneration;. In: Proteases in Tissue Remodelling of Lung and Heart. Editor: U Lendeckel U, Otto-von-Guericke University, Magdeburg, Germany and Hooper NM, University of Leeds, UK. Kluwer Academic Publishers ISBN: 0-306-47910-9, November 2003.